High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
作者信息
Gazzaruso Carmine, Carlo Stella Nicoletta, Mariani Giuseppe, Nai Carlo, Coppola Adriana, Naldani Daniela, Gallotti Pietro
机构信息
Emergency Unit and Endocrinology Unit, Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Corso Pavia, 84, 27029, Vigevano, Italy.
Centre for Applied Clinical Research (Ce.R.C.A.), Istituto Clinico "Beato Matteo" (Hospital Group San Donato), Vigevano, Italy.
出版信息
Clin Rheumatol. 2020 Jul;39(7):2095-2097. doi: 10.1007/s10067-020-05180-7. Epub 2020 May 27.
Abstract
摘要
相似文献
1
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.因新型冠状病毒肺炎住院患者中抗核抗体和狼疮抗凝物的高流行率。
Clin Rheumatol. 2020 Jul;39(7):2095-2097. doi: 10.1007/s10067-020-05180-7. Epub 2020 May 27.
2
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.新型冠状病毒2（SARS-CoV2）所致重症肺炎与非新型冠状病毒2所致重症肺炎凝血特征的差异
J Thromb Thrombolysis. 2021 May;51(4):1111-1112. doi: 10.1007/s11239-020-02115-6.
3
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
4
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）患者狼疮抗凝物阳性的评估
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
5
Lupus anticoagulant in patients with COVID-19.新型冠状病毒肺炎患者中的狼疮抗凝物
Int J Lab Hematol. 2021 Feb;43(1):e17-e18. doi: 10.1111/ijlh.13334. Epub 2020 Sep 11.
6
A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.一名患有新冠病毒相关脓胸和狼疮抗凝物的31岁男性。
Am J Case Rep. 2020 Aug 18;21:e926623. doi: 10.12659/AJCR.926623.
7
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020.2020 年 4 月至 6 月，泰国新冠肺炎康复病例的 SARS-CoV-2 病毒 RNA 脱落情况，以及新冠肺炎康复病例和密切接触者中针对 SARS-CoV-2 的抗体情况。
PLoS One. 2020 Oct 29;15(10):e0236905. doi: 10.1371/journal.pone.0236905. eCollection 2020.
8
Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?系统性红斑狼疮患者新型冠状病毒2型血清学检测更易出现假阳性吗？
Clin Exp Rheumatol. 2020 May-Jun;38(3):577. Epub 2020 May 27.
9
[First results of investigations of SARS-CoV‑2 RNA in human corneal tissue].[人角膜组织中SARS-CoV-2 RNA的初步研究结果]
Ophthalmologe. 2020 Jul;117(7):615-617. doi: 10.1007/s00347-020-01151-0.
10
Retinal involvement and ocular findings in COVID-19 pneumonia patients.COVID-19 肺炎患者的视网膜病变及眼部表现。
Sci Rep. 2020 Oct 15;10(1):17419. doi: 10.1038/s41598-020-74446-6.
引用本文的文献
1
Antiphospholipid antibodies in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者的抗磷脂抗体：一项系统评价与荟萃分析
J Thromb Thrombolysis. 2025 Jul 5. doi: 10.1007/s11239-025-03116-z.
2
The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.在患有肺炎和血管血栓形成的重症 COVID-19 病例中抗磷脂综合征的新出现可能解释 COVID 后综合征。
Biomedicines. 2025 Feb 19;13(2):516. doi: 10.3390/biomedicines13020516.
3
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.靶向血管紧张素转换酶2的自身抗体普遍存在，且非由SARS-CoV-2感染诱导产生。
FASEB J. 2025 Feb 28;39(4):e70390. doi: 10.1096/fj.202402694R.
4
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.新冠病毒病中的自身抗体：对疾病严重程度和临床结局的影响
Front Immunol. 2025 Jan 6;15:1509289. doi: 10.3389/fimmu.2024.1509289. eCollection 2024.
5
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature.由新型冠状病毒肺炎（COVID-19）引发的明确抗磷脂综合征：一例罕见病例报告及文献综述
Thromb J. 2024 Nov 8;22(1):99. doi: 10.1186/s12959-024-00669-6.
6
Demyelination in Patients with POST-COVID Depression.新冠后抑郁症患者的脱髓鞘病变
J Clin Med. 2024 Aug 9;13(16):4692. doi: 10.3390/jcm13164692.
7
Long COVID Definition, Symptoms, Risk Factors, Epidemiology and Autoimmunity: A Narrative Review.长新冠的定义、症状、风险因素、流行病学及自身免疫：一篇叙述性综述
Am J Med Open. 2024 Feb 14;11:100068. doi: 10.1016/j.ajmo.2024.100068. eCollection 2024 Jun.
8
The correlation between corona virus disease 2019 and alopecia areata: a literature review.新型冠状病毒病 2019 与斑秃的相关性：文献综述。
Front Immunol. 2024 Jul 3;15:1347311. doi: 10.3389/fimmu.2024.1347311. eCollection 2024.
9
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.巴瑞替尼联合脉冲激素治疗 COVID-19 超高炎症反应：重症监护室中的风湿学治疗方法。
Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.
10
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.抗核抗体（ANA）的出现作为COVID-19患者死亡和发病的潜在危险因素：一项单中心回顾性研究。
Biomedicines. 2024 Jun 13;12(6):1306. doi: 10.3390/biomedicines12061306.
本文引用的文献
1
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.冠状病毒病（COVID-19）的现状和未来展望：叙事性综述。
Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.
2
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
3
Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms.病毒与自身免疫：潜在相互作用和分子机制的综述。
Viruses. 2019 Aug 19;11(8):762. doi: 10.3390/v11080762.
Zotero 插件